A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
Clinical trial NCT05954910 · RECRUITING
Trial details
- NCT number
- NCT05954910
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-08-25
- Primary completion
- 2027-05-31
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.